Skip to main content

The DC-ren partner mosaiques diagnostics provides highly innovative Clinical Proteomics services for academic institutions and pharmaceutical companies

By February 12, 2024July 17th, 2024For the public & patients, Physicians & academics

First health insurance company in Germany pays for luxury urine test.

Hope for kidney patients. The test recognizes illnesses before they become a problem.

Proteome analysis can be used to detect kidney disease, heart disease, bladder cancer and benign and aggressive prostate cancer.

Newspaper article from Jana Quoos

BILD.de

03.02.2024

Link to publication

EU Flag DC-ren | Medical University Innsbruck

DC-ren has received funding from the European Union’s Horizon 2020 research and innovation programme under grant agreement No 848011.